DAOA variants and schizophrenia: Influence on diagnosis and treatment outcomes

References

• Martineau M, Baux G, Mothet JP. D-serine signalling in the brain: friend and foe. Trends Neurosci 2006;29(8):481–91.
   PubMedGoogle Scholar
• Schell MJ, Molliver ME, Snyder SH. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 1995; 92(9):3948–52.
   PubMedGoogle Scholar
• Kapoor R, Lim KS, Cheng A, Garrick T, Kapoor V. Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1). Brain research 2006;1106(1):205–10.
   PubMedGoogle Scholar
• Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H, . A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr Res 2007;90(1–3):41–51.
   PubMedGoogle Scholar
• Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 1996;3(5):241–53.
   PubMedGoogle Scholar
• Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, . Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002;99(21):13675–80.
   PubMedGoogle Scholar
• Benzel I, Kew JN, Viknaraja R, Kelly F, de Belleroche J, Hirsch S, . Investigation of G72 (DAOA) expression in the human brain. BMC Psychiatry 2008;8:94.
   PubMed Web of Science ®Google Scholar
• Detera-Wadleigh SD, McMahon FJ. G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 2006;60(2):106–14.
   PubMedGoogle Scholar
• Kvajo M, Dhilla A, Swor DE, Karayiorgou M, Gogos JA. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry 2008;13(7):685–96.
   PubMedGoogle Scholar
• Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, . Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 1998;20(1):70–3.
   PubMedGoogle Scholar
• Brzustowicz LM, Honer WG, Chow EW, Little D, Hogan J, Hodgkinson K, . Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet 1999;65(4): 1096–103.
   PubMedGoogle Scholar
• Camp NJ, Neuhausen SL, Tiobech J, Polloi A, Coon H, Myles-Worsley M. Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method. Am J Hum Genet 2001;69(6):1278–89.
   PubMedGoogle Scholar
• Faraone SV, Skol AD, Tsuang DW, Bingham S, Young KA, Prabhudesai S, . Linkage of chromosome 13q32 to schizophrenia in a large veterans affairs cooperative study sample. Am J Med Genet 2002;114(6):598–604.
   PubMedGoogle Scholar
• Levinson DF, Holmans P, Straub RE, Owen MJ, Wildenauer DB, Gejman PV, . Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet 2000;67(3):652–63.
   PubMedGoogle Scholar
• Lin MW, Sham P, Hwu HG, Collier D, Murray R, Powell JF. Suggestive evidence for linkage of schizophrenia to markers on chromosome 13 in Caucasian but not Oriental populations. Hum Genet 1997;99(3):417–20.
   PubMedGoogle Scholar
• Mulle JG, McDonough JA, Chowdari KV, Nimgaonkar V, Chakravarti A. Evidence for linkage to chromosome 13q32 in an independent sample of schizophrenia families. Mol Psychiatry 2005;10(5):429–31.
   PubMedGoogle Scholar
• Korostishevsky M, Kaganovich M, Cholostoy A, Ashkenazi M, Ratner Y, Dahary D, . Is the G72/G30 locus associated with schizophrenia? single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 2004;56(3):169–76.
   PubMedGoogle Scholar
• Habl G, Zink M, Petroianu G, Bauer M, Schneider-Axmann T, von Wilmsdorff M, . Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study. J Neural Transm 2009;116(12): 1657–65.
   PubMedGoogle Scholar
• Shi J, Badner JA, Gershon ES, Liu C. Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res 2008;98(1–3):89–97.
   PubMedGoogle Scholar
• Abou Jamra R, Schmael C, Cichon S, Rietschel M, Schumacher J, Nothen MM. The G72/G30 gene locus in psychiatric disorders: a challenge to diagnostic boundaries? Schizophr Bull 2006;32(4):599–608.
   PubMedGoogle Scholar
• Maheshwari M, Shi J, Badner JA, Skol A, Willour VL, Muzny DM, . Common and rare variants of DAOA in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2009; 150B(7):960–6.
   PubMedGoogle Scholar
• Rietschel M, Beckmann L, Strohmaier J, Georgi A, Karpushova A, Schirmbeck F, . G72 and its association with major depression and neuroticism in large population-based groups from Germany. Am J Psychiatr 2008;165:753–62.
   PubMedGoogle Scholar
• Liu YL, Fann CS, Liu CM, Chang CC, Wu JY, Hung SI, . No association of G72 and D-amino acid oxidase genes with schizophrenia. Schizophr Res 2006;87(1–3):15–20.
   PubMedGoogle Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22–33; quiz 4–57.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13(2):261–76.
   PubMed Web of Science ®Google Scholar
• Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005;162(3):441–9.
   PubMedGoogle Scholar
• Flemenbaum A, Zimmermann RL. Inter- and intra-rater reliability of the Brief Psychiatric Rating Scale. Psychol Rep 1973;32(3):783–92.
   PubMedGoogle Scholar
• StatSoft Inc. STATISTICA per Windows, StatSoft Italia, 1995.
   Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21(2):263–5.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125(1–2):279–84.
   PubMedGoogle Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
   Google Scholar
• Owen MJ, Craddock N, Jablensky A. The genetic deconstruction of psychosis. Schizophr Bull 2007;33(4): 905–11.
   PubMedGoogle Scholar
• Yue W, Kang G, Zhang Y, Qu M, Tang F, Han Y, . Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects. Neurosci Lett 2007; 416(1):96–100.
   PubMedGoogle Scholar
• Pae CU, Chiesa A, Serretti A. Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole. Psychiatry Res 2010;178(2):430–2.
   PubMedGoogle Scholar
• Mouri A, Noda Y, Enomoto T, Nabeshima T. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem Int 2007;51(2–4):173–84.
   PubMedGoogle Scholar
• Sullivan PF. Spurious genetic associations. Biol Psychiatry 2007;61(10):1121–6.
   PubMedGoogle Scholar
• Cavalli Sforza L. The History and Geography of Human Genes. Princeton, NJ: Princeton University Press; 1994.
   Google Scholar
• Fanous AH, Kendler KS. Genetics of clinical features and subtypes of schizophrenia: a review of the recent literature. Curr Psychiatry Rep 2008;10(2):164–70.
   PubMedGoogle Scholar
• Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002;159(3):469–73.
   PubMed Web of Science ®Google Scholar